SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia's stock is surging amidst discussions of potential deals with China, highlighted by Trump's upcoming meeting with Xi Jinping regarding Nvidia's Blackwell chip. The community is buzzing about the possibility of significant revenue growth and new partnerships, with some speculating on a potential market cap increase. Bullish analysts suggest the market may be underestimating AI demand and Nvidia's potential.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

$BROKE is trending amid community excitement around upcoming token burns tied to watcher milestones and general bullish sentiment. The community emphasizes its commitment to the project's long-term development, revenue-generating utilities, and a strong connection between Web2 and Web3. Discussions also highlight staking opportunities and the team's dedication.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending as the community discusses its ecosystem and potential ETF approvals. Conversations revolve around the network's efficiency and the integration of real-world partnerships, as well as airdrops. Certain meme tokens built on $SOL, like $WAGMI and $BROKE, are also seeing increased attention.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is trending, particularly among the Solana ($SOL) community, with increased mentions of 'PUMP'. Discussions highlight community support and the shared goal of success, reflected in its ticker: 'We're All Gonna Make It'.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending following a Q3 earnings call that highlighted rapid progress in obesity studies and potential M&A interest in its MASH assets, leading to analyst upgrades and renewed optimism. Community discussions focus on the company's strategic options, including partnerships and going it alone, with many believing Viking is undervalued given its pipeline. The stock is seen as a key player in the competitive GLP-1 and MASH space, with potential for significant growth.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy Corp

Bloom Energy ($BE) is trending following news of a $5 billion partnership with Brookfield to power AI data centers, driving significant overnight gains. Community discussions revolve around whether this surge is justified and sustainable, considering Bloom's valuation and profitability.  Some see the company as a key player in meeting the growing energy demands of AI, while others suggest caution due to the stock's rapid rise and high P/E ratio.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is surging amid news of a significant investment from Nvidia, fueling discussions about its potential in AI and 6G technology; the community is buzzing over the partnership's implications for Nokia's future and its role in the AI-driven telecom landscape. The stock's sudden move is prompting debates about whether this is a long-term shift or a short-lived hype, with some eyeing potential pullbacks while others anticipate further gains.

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, the TRICARE program, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

Centene Corp.

Centene Corp. ($CNC) is trending as investors react to the company's recent earnings beat and future outlook. The community is discussing the significance of Medicaid health benefit ratios and robust guidance expectations, with some expressing confidence in CEO Sarah London's leadership.  Traders are weighing bullish earnings results against broader sector concerns, including government shutdowns and potential ACA subsidy changes.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as the market rallies, fueled by AI optimism and anticipation surrounding big tech earnings and the Fed's rate decision. Community chatter revolves around the sustainability of the current uptrend, potential pullbacks, and whether the market is in a bubble. Some are attributing the rise to a handful of mega-cap tech stocks and the influence of high-frequency trading.

Pump.fun

$PUMP is trending as community members express strong bullish sentiment and 'WAGMI' (We're All Gonna Make It) mentality, particularly within the Solana ecosystem. Discussions revolve around potential breakouts, long-term holding strategies, and the coin's potential to reach new price levels. The community highlights the coin's resilience and continuous grinding despite market fluctuations.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$IFRX $PFE $NVS crazy now there’s all of a sudden a bunch of interest in inflammation w $b deals. 

IL6 a different MOA / path - but are we finally getting attention on what inflammation does to organs - brain?

“Novartis is paying $1.4 billion to acquire Tourmaline Bio and its sole drug, pacibekitug, an interleukin (IL)-6-targeted antibody for tackling inflammation leading to atherosclerotic cardiovascular disease. The repositioned IL-6 inhibitor, in-licensed from Pfizer, showed effects on a key biomarker and is set for phase 3 trials. Inflammation is known risk factor for cardiovascular disease, but current therapies mainly target high cholesterol.”

https://www.nature.com/articles/s41587-025-02885-5

CIELO1

FlowerInTheCellar

Marcel G.

StartSlow

avalon E

test

Novartis is paying $1.4 billion to acquire Tourmaline Bio and its sole drug, pacibekitug, an interleukin (IL)-6-targeted antibody for tackling inflammation leading to atherosclerotic cardiovascular disease. The repositioned IL-6 inhibitor, in-licensed from Pfizer, showed effects on a key biomarker and is set for phase 3 trials.

Nature

IL-6 antibody in $1.4 billion sale - Nature Biotechnology

StockTwits for iOS

InflaRx N.V.

Pfizer Inc

Novartis AG

Barrick Mining Corp

 crazy now there’s all of a sudden a bunch of interest in inflammation w 

 deals. 

IL6 a different MOA / path - but are we finally getting attention on what inflammation does to organs - brain?

“Novartis is paying $1.4 billion to acquire Tourmaline Bio and its sole drug, pacibekitug, an interleukin (IL)-6-targeted antibody for tackling inflammation leading to atherosclerotic cardiovascular disease. The repositioned IL-6 inhibitor, in-licensed from Pfizer, showed effects on a key biomarker and is set for phase 3 trials. Inflammation is known risk factor for cardiovascular disease, but current therapies mainly target high cholesterol.”



@dogDazeSummer waky waky Roche!  Deal in Europe and USA for 1 or 2 indications!!! $RHHBY

StockTwits For Android 

Roche Holdings AG ADR

 waky waky Roche!  Deal in Europe and USA for 1 or 2 indications!!! 

@dogDazeSummer Same old same old.  What’s the effector cell and which signaling is primary to its activation?  To that I wonder why BARDA didn’t choose IL6/R signal blocking biotech in their ARDS study. 
 
https://stocktwits.com/MrCompassion/message/633026584

IFRX Our number one killer, CVD. "Cardiovascular diseases (CVDs) remain the leading cause of death worldwide, accounting for millions of deaths annually and placing a considerable burden on healthcare systems. In 2021, heart disease and stroke were responsible for 20.5 million deaths, representing approximately one-third of all deaths globally."

Stocktwits

MrC (@MrCompassion) | Stocktwits

StockTwits Web

 Same old same old.  What’s the effector cell and which signaling is primary to its activation?  To that I wonder why BARDA didn’t choose IL6/R signal blocking biotech in their ARDS study. 
 
